Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
7
8
Next >
BioMarin Sells Priority Review Voucher For $110M
February 09, 2022
Tickers
BMRN
Tags
News
Market News
General
From
Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
Tickers
ADGI
ALLK
ALNY
ARGX
Tags
DNLI
BBIO
PRAX
From
MarketWatch
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
News
Market News
General
From
Benzinga
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
Tickers
BMRN
CORT
CPRX
Tags
Market News
CORT
CPRX
From
Motley Fool
This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
November 25, 2021
Tickers
BMRN
Tags
Trading Ideas
Movers
Markets
From
Benzinga
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
Tickers
BMRN
Tags
Benzinga
Market News
Trading Ideas
From
Benzinga
Where Biomarin Pharmaceutical Stands With Analysts
November 22, 2021
Tickers
BMRN
Tags
Benzinga
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Tickers
ADBE
AIP
ALNY
ASPU
Tags
LNSR
STNE
EOSE
From
Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
Tickers
ALNY
AMGN
ATVI
BMRN
Tags
ETSY
AMGN
RDFN
From
Benzinga
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
Tickers
BMRN
Tags
Recent Press Releases
BMRN
Market News
From
Motley Fool
FDA Conditionally Approves Biomarin's Dwarfism Drug
November 19, 2021
Tickers
BMRN
Tags
General
Long Ideas
Market News
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
BIIB
Rumors
News
From
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Tickers
ACRX
AMRN
ATHX
AYTU
Tags
MDWD
MLSS
VTYX
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
Tickers
AADI
AMYT
BMRN
BYSI
Tags
ETON
Biotech
BMRN
From
Benzinga
BioMarin's Q3 Net Income Hit By Lower Product Sales
October 28, 2021
Tickers
BMRN
Tags
General
Benzinga
Market News
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BMRN
Tags
Market News
BMRN
From
Motley Fool
Biomarin Pharmaceutical: Q3 Earnings Insights
October 27, 2021
Tickers
BMRN
Tags
BZI/Recaps
Benzinga
Earnings
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
JNJ
ADAP
CDNA
From
Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
Tickers
BLUE
BMRN
BMY
JNJ
Tags
JNJ
BMY
LEGN
From
Motley Fool
The Smartest Stocks to Buy With $250 Right Now
October 22, 2021
Tickers
BMRN
FRPT
GRWG
Tags
Market News
BMRN
GRWG
From
Motley Fool
Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More
October 16, 2021
Tickers
AAPL
AMZN
BMRN
C
Tags
C
AMZN
AAPL
From
Benzinga
Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug
September 09, 2021
Tickers
BMRN
Tags
General
dwarfism
Price Target
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Tickers
ALGS
AMRN
APEN
APP
Tags
VOSSY
AVIR
RKLB
From
Benzinga
Price To Earnings Ratio Insights For Biomarin Pharmaceutical
September 07, 2021
Tickers
BMRN
Tags
Intraday Update
Benzinga
News
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 07, 2021
Tickers
ADAP
APOP
BMRN
FWP
Tags
Benzinga
LEXX
Pre/Market Outlook
From
Benzinga
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
September 07, 2021
Tickers
BMRN
Tags
BMRN
Briefs
Biotech
From
Benzinga
Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval
August 27, 2021
Tickers
BMRN
Tags
achondroplasia
Briefs
Health Care
From
Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
August 20, 2021
Tickers
ASND
BMRN
Tags
Market News
ASND
BMRN
From
Motley Fool
BioMarin Bounces Back With Solid Q2 Earnings, Nudges Up 2021 Guidance
July 29, 2021
Tickers
BMRN
Tags
General
Benzinga
Market News
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
July 29, 2021
Tickers
BMRN
Tags
Market News
BMRN
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today